Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

The Fall 2022 edition of the CBS Newsletter has been released. You can access it here.

The 38th CBS annual meeting with be held at Dalhousie University in Halifax, Nova Scotia. Call for abstracts opens December 1st, 2022, and the Early Bird registration deadline is March 1st, 2023...

The Canadian Biomaterials Society is pleased to present The 2022-2023 CBS mentorship and Professional Development Program Join The 2nd Lab and the CBS-QC Student Chapter this Friday, October 7th, 2022 at 5 00 PM for a hybrid information session about this program...

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Cell therapy is increasingly used to treat various diseases such myocardial infarction. This therapeutic approach is limited however by the poor retention and diminished survival of transplanted cells in the ischemic, inflammatory and oxidative infarct microenvironment...

There are significant limitations side effects to all breast cancer chemotherapy regimens, radiation and surgical treatments, which urgently warrant a search for alternative and more effective therapies...

Thermosensitive chitosan CH -based hydrogels that rapidly pass from a liquid at room temperature to a mechanically stable solid at body temperature without any crosslinker show excellent potential for tissue engineering applications and could be interesting candidates for bioprinting ADDIN EN...

Cardiovascular disease CVD is the cause of approximately one third of Canadian and American mortalities each year 1,2 ...

Vascular tissue engineering has made significant advancement over the past decades toward the definition of optimal scaffolds, cell sources, and biomechanical culture parameters for obtaining engineered tissue ET products that resemble native tissues...